Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB

References

• Béduneau A, Hindré F, Clavreul A, et al. Brain targeting using novel lipid nanovectors. J Control Release 2008;126:44–9
   PubMed Web of Science ®Google Scholar
• Gururangan S, Friedman HS. Innovations in design and delivery of chemotherapy for brain tumors. Neuroimaging Clin N Am 2001;12:583–97
   Web of Science ®Google Scholar
• Juillerat-Jeanneret L. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? Drug Discov Today 2008;13:1099–106
   PubMed Web of Science ®Google Scholar
• Jiang XY, Xin HL, Sha XY, et al. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Int J Pharm 2011;420:385–94
   PubMed Web of Science ®Google Scholar
• Hu KL, Shi YB, Jiang WM, et al. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson’s disease. Int J Pharm 2011;415:273–83
   PubMed Web of Science ®Google Scholar
• Huwyler J, Wu D, Pardridge WM. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci USA 1996;93:14164–9
   PubMed Web of Science ®Google Scholar
• Bao HM, Jin X, Li L, et al. OX26 modified heperbranchedpolyglycerol-conjugated poly(lactic-co-glycolic acid) nanoparticles: synthesis, characterization and evaluztion of its brain delivery ability. J Mater Sci Mater Med 2012;23:1891–901
   PubMed Web of Science ®Google Scholar
• Pang ZQ, Lu W, Gao HL, et al. Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. J Control Release 2008;128:120–7
   PubMed Web of Science ®Google Scholar
• Jain KK. Use of nanoparticles for drug delivery in glioblastomamultiforme. Expert Rev Neurother 2007;7:363–72
   PubMed Web of Science ®Google Scholar
• Lockman PR, Koziara JM, Mumper RJ, Allen DD. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 2004;12:635–41
   PubMed Web of Science ®Google Scholar
• Cao YG, Mao XY, Sun CY, et al. Baicalin attenuates global cerebral ischemia/reperfusion injury in gerbils via anti-oxidative and anti-apoptotic pathways. Brain Res Bull 2011;85:396–402
   PubMed Web of Science ®Google Scholar
• Ellmann GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70–7
   PubMed Web of Science ®Google Scholar
• Olivier JC, Huertas R, Lee HJ, et al. Synthesis of pegylatedimmunonanoparticles. Pharm Res 2002;19:1137–43
   PubMed Web of Science ®Google Scholar
• Lu W, Zhang Y, Tan YZ, et al. Cationic albumin-conjugatedpegylated nanoparticles as novel drug carrier for brain delivery. J Control Release 2005;107:428–48
   PubMed Web of Science ®Google Scholar
• Yue PF, Lu XY, Zhang ZZ, et al. The study on the entrapment efficiency and in vitro release of puerarin submicronemulsion. AAPS PharmSciTech 2009;10:376–83
   PubMed Web of Science ®Google Scholar
• Wang XM, He HB, Leng W, Tang X. Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method. Int J Pharm 2006;317:40–6
   PubMed Web of Science ®Google Scholar
• Higuchi T. Physical chemical analysis of percutaneous absorption process from creams and ointments. J Soc Cosmet Chem 1960;11:85–9
   Web of Science ®Google Scholar
• Laine AL, Huynh NT, Clavreul A, et al. Brain tumor targeting strategies via coated ferrociphenol lipid nanocapsules. Eur J Pharm Biopharm 2012;81:690–3
   PubMed Web of Science ®Google Scholar
• Jain A, Chasoo G, Singh SK, et al. Transferrin-appended PEGylation nanoparticles for temozolomide delivery to brain: in-vitro characterization. J Microencapsul 2011;28:21–8
   PubMed Web of Science ®Google Scholar
• Liu ZD, Zhang XH, Wu HY, et al. Preparation and evaluation of solid Lipid Nanoparticles of Baicalin for ocular drug delivery system in vitro and in vivo. Drug Dev Ind Pharm 2011;37:475–81
   PubMed Web of Science ®Google Scholar
• Liu LH, Guo K, Lu J, et al. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG–TAT for drug delivery across the blood-brain barrier. J Biomaterials 2008;29:1509–17
   PubMed Web of Science ®Google Scholar
• Kanayama N, Takarada T, Kimura A, et al. Poly(ethyleneglycol)-oligodeoxyribonucleotide block copolymers for affinity capillary electrophoretic separation of single-stranded DNAs with a single-base difference. J React Funct Polym 2007;67:1373–80
   Web of Science ®Google Scholar
• Bungay PM, Morrison PF, Dedrick RL. Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro. Life Sci 1990;46:105–19
   PubMed Web of Science ®Google Scholar
• Bungay PF, Hsiao JK, Ball BA, et al. Quantitative microdialysis: analysis of transient and application to pharmacokinetics in brain. J Neurochem 1991;57:103–19
   PubMed Web of Science ®Google Scholar
• Benveniste H, Hansen AJ, Ottosen NS. Determination of brain interstitial concentrations by microdialysis. J Neurochem 1991;57:1741–50
   Google Scholar
• Liu ZD, Yang XG, Li JW, et al. Study on the ocular pharmacokinetics of ion-activated in situ gelling ophthalmic delivery system for gatifloxacin by microdialysis. Drug Dev Ind Pharm 2007;33:1327–31
   PubMed Web of Science ®Google Scholar
• Tömböly C, Péter A, Tóth, G. In vitro quantitative study of the degradation of endomorphins. Peptides 2002;23:1573–80
   PubMed Web of Science ®Google Scholar
• Sugiyama I, Sadzuka Y. Characterization of novel mixed polyethylene glycol modified liposomes. Biol Pharm Bull 2007;30:208–11
   PubMed Web of Science ®Google Scholar
• Wohlfart S, Gelperina S, Kreuter J. Transport of drugs across the blood-brain barrier by nanoparticles. J Control Release 2012;161:264–73
   PubMed Web of Science ®Google Scholar
• Hillaireau H, Couvreur P. Nanocarriers’ entry into the cell: relevance to drug delivery. Cell Mol Life Sci 2009;66:2873–96
   PubMed Web of Science ®Google Scholar